Abbott Vascular Medical Device Registry
Launched by ABBOTT MEDICAL DEVICES · Sep 30, 2020
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
The Abbott Vascular Medical Device Registry is a clinical study designed to collect and evaluate information about specific medical devices used to treat certain heart and blood vessel conditions, such as heart attacks and blood clots. The goal of this study is to ensure these devices are safe and effective throughout their use, and to identify any new risks that might arise. It is an ongoing study that is currently looking for participants.
To be eligible, you need to be at least 18 years old and have a scheduled or recent procedure that involves one of the Abbott devices included in the study. Participants will need to agree to follow a set schedule for check-ups after the procedure. It’s important to note that if you have had symptoms of COVID-19 or another contagious illness in the last two months, you may not qualify for this study. If you decide to participate, you will provide informed consent, which means you understand the study and agree to take part before any data is collected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subject is at least 18 years of age.
- • 2. Subject has a planned procedure, or underwent a procedure, that will use/used one or more Abbott target devices covered in this registry.
- • 3. Subject is willing and able to comply with, or has already completed, the follow-up schedule specified in this protocol.
- • 4. Subject must provide written informed consent prior to any clinical investigation-related data collection or be enrolled under an IRB/EC approved waiver of consent.
- Exclusion Criteria:
- • 1. Subject has active symptoms and/or a positive test result of COVID-19 or other rapidly spreading novel infectious agent within the prior 2 months of the date of procedure.
About Abbott Medical Devices
Abbott Medical Devices is a leading global healthcare company dedicated to advancing medical technology through innovative research and development. With a robust portfolio of diagnostic, therapeutic, and monitoring solutions, Abbott is committed to improving patient outcomes and enhancing the quality of care across various medical fields. The company places a strong emphasis on clinical trials to validate the safety and efficacy of its products, ensuring compliance with regulatory standards and fostering collaboration with healthcare professionals. By leveraging cutting-edge science and technology, Abbott Medical Devices aims to address pressing health challenges and deliver transformative solutions that empower patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Chicago, Illinois, United States
Los Angeles, California, United States
Barcelona, , Spain
Little Rock, Arkansas, United States
Madrid, , Spain
Budapest, , Hungary
Xi'an, Shaanxi, China
Kingsport, Tennessee, United States
Lincoln, Nebraska, United States
Birmingham, Alabama, United States
Leipzig, Saxony, Germany
Nieuwegein, Utrecht, Netherlands
Frankfurt, Hesse, Germany
Sharjah, , United Arab Emirates
Aalst, Eflndrs, Belgium
Mainz, Rhinela, Germany
Milano, Lombard, Italy
Aarau, Basel, Switzerland
Milano, Lombard, Italy
Bern, , Switzerland
Graz, Styria, Austria
San Donato Milanese, Lombard, Italy
Nedlands, Waus, Australia
Nedlands, Waus, Australia
Dendermonde, Eflndrs, Belgium
Bad Bevensen, Saxon, Germany
Kiel, Schlesw, Germany
Taichung, Mtaiwan, Taiwan
Taipei City, Ntaiwan, Taiwan
Tainan City, Staiwan, Taiwan
Tainan City, Staiwan, Taiwan
Ningbo, Zhejian, China
Chartres, Centre, France
Paris, Ile, France
Alicante, Valncia, Spain
Jinhua, Zhejian, China
Patients applied
Trial Officials
Chananit Hutson, PhD
Study Director
Abbott Medical Devices
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials